Jeanny Aragon-ching

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    EMD Serono
    Topic:
    Bladder cancer avelumab
    Date added:
    08/28/2024
    Date updated:
    03/14/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Novartis
    Topic:
    Prostate cancer
    Date added:
    08/28/2024
    Date updated:
    03/14/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Pfizer
    Topic:
    Talazoparib/Enzalutamide Prostate cancer
    Date added:
    03/14/2025
    Date updated:
    03/14/2025

Pages

Return to 2025 Inova Fairfax Genitourinary (GU) Cancer Case Conference 12/03/2025